TTK/MPS1 inhibitor OSU-13 targets the mitotic checkpoint and is a potential therapeutic strategy for myeloma

Despite substantial recent advances in treatment, multiple myeloma (MM) remains an incurable disease, with a shortage of treatment options for patients with high-risk disease, warranting the need for novel therapeutic targets and treatment approaches. Threonine and tyrosine kinase (TTK), also known...

Full description

Bibliographic Details

Published in:	Haematologica
Main Authors:	Larissa Valle Guilhen Longo, Tiffany Hughes, Betina McNeil-Laidley, Francesca Cottini, Gerard Hilinski, Elizabeth Merritt, Don M. Benson
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2023-07-01
Online Access:	https://haematologica.org/article/view/11182